Aug 232016

I was interviewed on KCBS on August 23, 2016 on Mylan’s 400% price increase of anti-allergy drug EpiPen.

Note:  Last fall, Charlie Munger, Berkshire Hathaway’s vice chairman, described Valeant Pharmaceutical’s similar behavior of substantially increasing the prices of drugs that it had purchased from other pharmaceutical companies as “deeply immoral”.


 Posted by at 11:06 pm

Sorry, the comment form is closed at this time.